Table 2.
Association Between MRPL13 Expression and Clinicopathological Characteristics from UALCAN Website
| Comparison | Statistical Significance |
|---|---|
| Nodal metastasis status | |
| Normal-vs-N0 | 1.62E-12 |
| Normal-vs-N1 | 1.62E-12 |
| Normal-vs-N2 | 4.38E-07 |
| Normal-vs-N3 | 2.95E-12 |
| N0-vs-N1 | 9.77E-01 |
| N0-vs-N2 | 4.72E-02 |
| N0-vs-N3 | 8.68E-01 |
| N1-vs-N2 | 4.78E-02 |
| Cancer subclasses | |
| Normal-vs-Luminal | <1E-12 |
| Normal-vs-HER2 Positive | 3.42E-07 |
| Normal-vs-TNBC | <1E-12 |
| Cancer stages | |
| Normal-vs-Stage1 | 1.62E-12 |
| Normal-vs-Stage2 | <1E-12 |
| Normal-vs-Stage3 | 2.74E-14 |
| Normal-vs-Stage4 | 2.24E-03 |
| Stage1-vs-Stage3 | 3.83E-02 |